{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioTech Nation ... with Dr. Moira Gunn","title":"23-03 Dr. Rob Ross, CEO, Surface Oncology","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/d49b7b7d\"></iframe>","width":"100%","height":180,"duration":974,"description":"Surface Oncology's strategy to improve on the first generation of immuno-oncology drugs. Their Phase 2 trials in lung cancer and liver cancer are underway and recruiting.","thumbnail_url":"https://img.transistorcdn.com/2O-bvNE3apnAmlMA6TtfHcDLDnv2fCS4nzWuofCE46M/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzMxMTgyLzE2NTM3/NjI1NzctYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}